메디컬 이미징 시장 보고서 : 제품별, 용도별, 최종사용자별, 지역별(2025-2033년)

The global medical imaging market size reached USD 44.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 70.8 Billion by 2033, exhibiting a growth rate (CAGR) of 5.03% during 2025-2033. The market is experiencing robust growth, driven by rapid technological advancements, the rising prevalence of chronic diseases, increasing demand for early diagnosis, expanding healthcare infrastructure and the growing geriatric population.

Medical imaging refers to the technique of creating visual depictions of the human body for diagnosing an ailment and its subsequent medical treatment. Computed tomography (CT) scanners, magnetic resonance imaging (MRI), nuclear imaging, mammography, and ultrasound are common medical imaging systems. It is a non-invasive technique that helps medical professionals to assess patients' bones, organs, tissue, and blood vessels. Medical imaging tests are safe, quick, and easy to perform and aid in early and accurate diagnosis, understanding complications, and eliminating the need for exploratory surgery. As a result, medical imaging is widely used in cardiovascular and thoracic, orthopedics and musculoskeletal, obstetrics and gynecology, and neurology departments.

Medical Imaging Market Trends:

The significant growth in the healthcare industry across the globe is creating a positive outlook for the market. In line with this, the growing occurrence of lifestyle diseases owing to sedentary lifestyles and age-related ailments in the steadily rising geriatric population is also favoring the market growth. Medical imaging is widely used by healthcare specialties to diagnose diseases and injuries, such as cancer, heart blockage, fractures, and tumors. Apart from this, the introduction of three-dimensional (3D) imaging technology to develop enhanced resolutions and more intricate details for better patient care is providing an impetus to the market growth. Moreover, the integration of artificial intelligence (AI) to enhance tissue-based detection and provide accuracy and sensitivity in the identification of imaging abnormalities is acting as another growth-inducing factor. Furthermore, the increasing demand for CT scans and MRIs to detect the spread of COVID-19 in the lungs is positively influencing the market growth. Other factors, including rising expenditure capacities of consumers, extensive research and development (R&D) activities, and the launch of portable imaging devices, are anticipated to drive the market growth.

Key Market Segmentation:

Breakup by Product:

• CT Scanners
• X-Ray Imaging Systems
• MRI Systems
• Ultrasound Imaging Systems
• Nuclear Imaging Systems
• Mammography Systems

Breakup by Application:

• Obstetrics and Gynecology Health
• Orthopedics and Musculoskeletal
• Neuro and Spine
• Cardiovascular and Thoracic
• General Imaging
• Breast Health
• Others

Breakup by End User:

• Hospitals
• Diagnostic Centers
• Academic Institutes and Research Organizations

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Canon Medical Systems Corporation (Canon Inc.), Carestream Health, Cubresa Inc., Esaote SpA, FUJIFILM VisualSonics Inc., GE HealthCare (General Electric Company), Hologic Inc., Koning Corporation, Koninklijke Philips N.V., Materialise NV, Mindray Medical International Limited, Samsung Medison Co. Ltd. (Samsung Electronics Co. Ltd.) and Siemens Healthineers AG (Siemens AG).

Key Questions Answered in This Report

• 1.What was the size of the global medical imaging market in 2024?
• 2.What is the expected growth rate of the global medical imaging market during 2025-2033?
• 3.What are the key factors driving the global medical imaging market?
• 4.What has been the impact of COVID-19 on the global medical imaging market?
• 5.What is the breakup of the global medical imaging market based on the product?
• 6.What is the breakup of the global medical imaging market based on the application?
• 7.What is the breakup of the global medical imaging market based on the end user?
• 8.What are the key regions in the global medical imaging market?
• 9.Who are the key players/companies in the global medical imaging market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Medical Imaging Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 CT Scanners
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 X-Ray Imaging Systems
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 MRI Systems
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Ultrasound Imaging Systems
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast
• 6.5 Nuclear Imaging Systems
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast
• 6.6 Mammography Systems
  • 6.6.1 Market Trends
  • 6.6.2 Market Forecast

7 Market Breakup by Application

• 7.1 Obstetrics and Gynecology Health
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Orthopedics and Musculoskeletal
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Neuro and Spine
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Cardiovascular and Thoracic
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 General Imaging
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast
• 7.6 Breast Health
  • 7.6.1 Market Trends
  • 7.6.2 Market Forecast
• 7.7 Others
  • 7.7.1 Market Trends
  • 7.7.2 Market Forecast

8 Market Breakup by End User

• 8.1 Hospitals
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Diagnostic Centers
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Academic Institutes and Research Organizations
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Canon Medical Systems Corporation (Canon Inc.)
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
  • 14.3.2 Carestream Health
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
  • 14.3.3 Cubresa Inc.
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
  • 14.3.4 Esaote SpA
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
  • 14.3.5 FUJIFILM VisualSonics Inc.
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
  • 14.3.6 GE HealthCare (General Electric Company)
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
  • 14.3.7 Hologic Inc.
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
  • 14.3.8 Koning Corporation
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
  • 14.3.9 Koninklijke Philips N.V.
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
  • 14.3.10 Materialise NV
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
  • 14.3.11 Mindray Medical International Limited
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
  • 14.3.12 Samsung Medison Co. Ltd. (Samsung Electronics Co. Ltd.)
    • 14.3.12.1 Company Overview
    • 14.3.12.2 Product Portfolio
  • 14.3.13 Siemens Healthineers AG (Siemens AG)
    • 14.3.13.1 Company Overview
    • 14.3.13.2 Product Portfolio